InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Saturday, 11/18/2023 6:38:10 AM

Saturday, November 18, 2023 6:38:10 AM

Post# of 14871
Another study awaiting Testosterone approval. Though this article focusses on Estradiol, it looks like the best chance of reducing CV events may be linked to obtaining optimal Estradiol and Testosterone Levels. ANIP now has a generic Estradiol and it looks like testosterone is on deck.

Measurements of Postmenopausal Serum Estradiol Levels and Cardiovascular Events: A Systematic Review


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News